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Abstract
Background: W h o l eg e n o m eg e n ee x p r e s s i o np r o f i l i n ghas revolutionized research in the past
decade especially with the advent of microarrays. Recently, there have been significant
improvements in whole blood RNA isolation techniques which, through stabilization of RNA at
the time of sample collection, avoid bias and artifacts introduced during sample handling. Despite
these improvements, current human whole blood RNA stabilization/isolation kits are limited by the
requirement of a venous blood sample of at least 2.5 mL. While fingerstick blood collection has
been used for many different assays, there has yet to be a kit developed to isolate high quality RNA
for use in gene expression studies from such small human samples. The clinical and field testing
advantages of obtaining reliable and reproducible gene expression data from a fingerstick are many;
it is less invasive, time saving, more mobile, and eliminates the need of a trained phlebotomist.
Furthermore, this method could also be employed in small animal studies, i.e. mice, where larger
sample collections often require sacrificing the animal. In this study, we offer a rapid and simple
method to extract sufficient amounts of high quality total RNA from approximately 70 μlo fw h o l e
blood collected via a fingerstick using a modified protocol of the commercially available Qiagen
PAXgene RNA Blood Kit.
Results: From two sets of fingerstick collections, about 70 uL whole blood collected via finger
lancet and capillary tube, we recovered an average of 252.6 ng total RNA with an average RIN of
9.3. The post-amplification yields for 50 ng of total RNA averaged at 7.0 ug cDNA. The cDNA
hybridized to Affymetrix HG-U133 Plus 2.0 GeneChips had an average % Present call of 52.5%.
Both fingerstick collections were highly correlated with r
2 values ranging from 0.94 to 0.97.
Similarly both fingerstick collections were highly correlated to the venous collection with r
2 values
ranging from 0.88 to 0.96 for fingerstick collection 1 and 0.94 to 0.96 for fingerstick collection 2.
Conclusions: Our comparisons of RNA quality and gene expression data of the fingerstick
method with traditionally processed sample workflows demonstrate excellent RNA quality from
the capillary collection as well as very high correlations of gene expression data.
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Whole genome gene expression profiling has revolutio-
nized research in the past decade especially with the
advent of DNA microarrays [1-3]. This versatile techni-
que has facilitated the parallel interrogation of thou-
sands of RNA transcripts, simultaneously from a variety
of tissues. Keeping up with the pace of development of
DNA microarrays are several methods of RNA isolation
from tissues and cells, the critical first step in the
generation of data. More recently, to avoid bias as well as
manipulation of blood cells during their processing,
there are now a few commercial kits available for whole
blood RNA isolation and purification such as the
PAXgene system (Qiagen, Valencia, CA) and the Tempus
Blood RNA collection and Isolation system (Applied
Biosystems, Foster City, CA). These methods require at
least 2.5 mL blood via venipuncture that is collected into
a tube containing proprietary RNA stabilizing reagents
that simultaneously lyses the whole blood as well as
s t a b i l i z e st h eR N Aa tt h et i m eo fc o l l e c t i o nt h e r e b y
immobilizing and preventing further changes to the RNA
transcriptome. This method has been imperative for the
generation of reliable gene expression data from whole
blood where the RNA is highly susceptible to changes
and degradation during subsequent manipulation of the
blood cells creating significant artifacts of sample
collection and processing, especially when drawn in
clinical situations [4]
However, one limitation of such RNA stabilization
systems in humans is the requirement for the collection
of a venous blood sample, which involves a venipunc-
ture. Fingerstick capillary blood collection has been
widely used and has been shown to be very reliable.
A classic example of this methodology is blood glucose
monitoring. Fingerstick blood has also been used to test
for Helicobacter pylori infection [5,6], cholesterol [7,8],
glycosylated hemoglobin (A1c) levels [9] and syphilis
[9]. However, a review of the current literature reveals
that there are no protocols available for extracting
sufficient amounts of good quality total RNA from
much smaller amounts of starting material for use in
DNA microarray studies, specifically a droplet of blood
from a finger stick (50-100 ul). A recent study used
small volumes of blood (0.3mL was the smallest
sample) along with a modified PAXgene protocol to
obtain high quality RNA from paediatric samples, but
they still obtained their samples via venipuncture [10].
Another recent study used small volumes (50 - 500μL)
of mouse or rat blood, also with a modified PAXgene
protocol, to obtain high quality RNA in sufficient
amounts for microarray analysis [11]. In addition, there
is a new Qiagen RNeasy Protect Animal Blood System
protocol which promises to deliver high quality total
RNA from 100 or 500 μL aliquots of rat or mouse
blood. However, neither of these protocols were tested
for use with human blood. The currently available
Microtainer tubes from BD Biosciences are used for
larger volumes (250-500 μL) and have no RNA
stabilizing reagents making them unsuitable for DNA
microarray studies, particularly for peripheral blood
samples.
Obtaining reliable and reproducible gene expression
data from a fingerstick has obvious advantages in
clinical as well as field testing applications. A fingerstick
is arguably a less invasive, less time consuming and a
more mobile method of blood sample collection,
eliminating the need of a trained phlebotomist. The
utility of such a method is obvious in studies designed
to collect blood samples from physically active subjects
(i.e. soldiers and athletes) or for field studies in remote
and under-developed areas. Fingerstick blood collection
would also be of immense value in several types of
subjects where it is commonly difficult to collect venous
blood via venipuncture: infants and young children,
intravenous drug addicts, and very obese individuals.
The value of fingerstick capillary collection as opposed
to venipuncture can also be appreciated in study designs
where there is a need for serial sample collections or for
pharmacokinetic studies that involve gene expression
assays. This method could also be employed in small
animal studies or nonhuman primates. Therefore, a
fingerstick method of blood collection will broaden the
current range of genomic profiling possible. We also
b e l i e v et h a ti tw i l lb ea ni n t e g r a lp a r to fd i a g n o s i sa n d
serial monitoring of disease states in the future where
one can envision a hand-held device that could monitor
expression levels of validated panels of genomic
biomarkers, much like the glucose monitoring systems
of today.
In the present study, we offer a rapid and simple method
to extract sufficient amounts of high quality total RNA
from approximately 70 μl of whole blood collected via
fingerstick using a modified protocol of the commer-
cially available Qiagen PAXgene RNA Blood Kit. RNA
amplification, labeling, and fragmentation were per-
formed using the Nugen Ovation kits (Nugen, San
Carlos, CA). This approach hybridizes biotinylated
cDNA onto the microarray and has been shown to
perform with superior sensitivity especially with smaller
amounts of input RNA [12-14]. Our comparisons of
RNA quality and gene expression data with traditionally
processed sample workflows demonstrate excellent RNA
quality from the capillary collection as well as very high
correlations of gene expression data in comparisons of
venous and capillary blood collections.
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In order to test the success and reproducibility of the
fingerstick method of RNA isolation we took two
fingerstick capillary samples from 5 donors on two
separate days (four samples total from each donor, 20
total samples). From each collection time point we chose
one purified total RNA sample from each donor and
went forward with the RNA amplification, fragmentation
and hybridization protocols. A venous sample was also
collected in parallel from each of the donors by a trained
phlebotomist and processed according to standard
protocols to represent the established method http://
www.scripps.edu/researchservices/dna_array [15]. All
samples were assayed on Affymetrix HGU133 2.0
GeneChips using the Nugen standard array protocol for
cDNA hybridization (Nugen FL-Ovation™ cDNA Biotin
Module V2 - now called the Encore™ Biotin Module -
user guide, http://www.nugeninc.com/tasks/sites/nugen/
assets/File/user_guides/userguide_encore_biotin.pdf
[16].
Sample Collection, RNA Isolation, and
Purification - Fingerstick Method
Approximately 70 μL of blood collected via fingerstick
was combined with 200 μL PAXgene RNA stabilizing
reagent (a PAXgene Reagent:blood ratio of 2.86) and left
to incubate at room temperature for at least two hours as
per manufacturer suggestions (PAXgene Blood RNA Kit
handbook, http://www1.qiagen.com/Products/RnaSt-
abilizationPurification/DSP/PaxGeneBloodRnaKitIVD.
aspx#Tabs=t2 [17].
We followed the PAXgene Blood RNA kit (product#
762164) protocol for RNA isolation and purification,
with the exception of one modification. After the first
spin, we washed the pellet with 1 mL RNase free water
instead of 4 mL due to its small volume. We initially
tested a "scaled down" version of the entire PAXgene
protocol, but, through further testing, we found that
using the standard volumes of buffers and washes had
no effect on the yields and were easier to employ (data
not shown). Furthermore, we also found the DNase step
in the protocol was crucial for the yield and fidelity of
the amplified cDNA. Without the DNase step, contam-
inating DNA was subsequently amplified causing the
GAPDH and Actin ratios used as quality control metrics
on the GeneChips to be abnormally high (data not
shown).
RNA Yield, Purity and Integrity - Fingerstick Method
From 20 samples of 70 μL fingerstick blood, the average
total RNA yields ranged from 138 to 430 ng (average of
255.7 ± 72.6 ng) which was well above the maximum
of 50 ng required for the Nugen Ovation RNA
Amplification System v2 (Nugen, San Carlos, CA).
While we did experience higher than normal OD260/280
ratios, an average of 3.9 ± 1.35, and lower OD260/230
ratios, an average of 0.09 ± .07, we found that this did
not affect downstream applications and was probably
caused by the high concentration of salts in the elution
buffer relative to the low concentration of RNA http://
www.flychip.org.uk/protocols/gene_expression/rna_qc.
php [18]. To assess the quality of the RNA, the samples
were then run on the Agilent 2100 BioAnalyzer using an
RNA PicoChip. Due to sample anomalies identified by
t h es o f t w a r e ,t w oo ft h e2 0s a m p l e sw e r eu n a b l et ob e
assigned a RNA Integrity Number (RIN); however, the
traces looked normal and this appeared to have no affect
on downstream applications for these two samples. The
RIN numbers of the RNA from the remaining 18 samples
w e r eb e t w e e n8 . 9a n d9 . 9( a v e r a g eo f9 . 3±0 . 2 5 ) ,w h i c h
indicates RNA of high quality and integrity [19].
RNA Yield, Purity and Integrity - Venipuncture Method
The total RNA from the 5 normal venipuncture PAXgene
blood collection tubes was extracted and purified
according to the PAXgene Blood RNA kit (product#
762164) protocol. From 2.5 mL of blood the yield
ranged from 4.1 to 7.9 μg of total RNA (average 5.96 ±
1.5 μg) with an average OD260/280r a t i oo f2 . 0±0 . 0 3a n d
an average OD260/230 ratio of 1.0 ± 0.45. To assess the
quality and integrity of the RNA, the samples were then
run on the Agilent 2100 BioAnalyzer using an RNA
NanoChip. The average RIN of the 5 total RNA samples
obtained by venipuncture was 9.2 ± 0.09.
RNA Amplification, Labeling, and Fragmentation
50 ng total RNA from each donor was taken from all
three sample sets (fingerstick 1, fingerstick 2, and
venipuncture) and subsequently amplified using the
Nugen Ovation® RNA Amplification System V2 (Cat.#
3100) and Ovation® WB Reagent (Cat.# 1300). The total
RNA yields and Agilent traces for these 15 samples are
shown in Figure 1. After amplification, the samples were
purified according to the Nugen user guide instructions
using the Qiagen QIAquick® PCR Purification Kit
(Qiagen, Cat. #28104). As shown in Figure 2, the two
batches of fingerstick samples (10 total) had cDNA
yields ranging from 4.7 to 7.9 μg (average of 7.0 ± 0.88
μg), all satisfying the minimum requirement of 4.4 μg
cDNA needed for Affymetrix chipping. The average
OD260/280ratio of the 10 samples was 1.9 ± 0.01.
For the venipuncture samples (5 total), the cDNA
yields ranged from 8.2 to 9.3 μg (average of 8.6 ±
0.43 μg) (Figure 2) with an average OD260/280 ratio of
1.9 ± 0.01. Before fragmenting and labeling the cDNA
with the Nugen FL-Ovation™ cDNA Biotin Module V2
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mine quality of the amplified whole cDNA (Figure 2) and
the results showed that all three sample sets had a
consistent profile and size distribution across the RNA
input range, indicating cDNA of good quality for array
hybridization [Nugen Ovation RNA Amplification
System v2 Technical Report #1, http://www.nugeninc.
com/tasks/sites/nugen/assets/File/technical_documents/
techdoc_ov_ampv2_rep_01.pdf [20].
cDNA Hybridization and GeneChip Processing
4.4 μg of the labeled cDNA was then hybridized to
Affymetrix GeneChip® Human Genome U133 Plus 2.0
Arrays using the Nugen standard array protocol for cDNA
hybridization(Nugenuserguide).Followinghybridization,
thechipwasthenwashed,stainedandscannedaccordingto
standard Affymetrix protocol http://www.affymetrix.com/
support/downloads/manuals/expression_analysis_techni-
cal_manual.pdf [21].
GeneChip Data Quality Control
The Affymetrix quality metrics for the fingerstick samples
are given in Table 1 and all the Venipuncture samples in
T a b l e2 .B o t ht h ef i n g e r s t i c ka n dt h ev e n o u ss a m p l e sh a d
similar average background (30.8 vs. 29.5) and scale
factor (2.7 vs. 2.8). The average % present calls were
slightly higher for the venipuncture samples (56% vs.
52.5%). The fingerstick samples had higher 3’/5’ GAPDH
and b-Actin ratios on average.
Correlation Coefficients for Fingerstick and
Venipuncture Samples
We calculated correlation coefficients for each donor
comparing fingerstick collection 1 vs. fingerstick collec-
tion 2 and also each fingerstick collection vs. the
venipuncture collection (Table 3). Both fingerstick
collections were highly correlated with r
2 values ranging
from 0.94 to 0.97. Similarly both fingerstick collections
were highly correlated to the venous collection with r
2
values ranging from 0.88 to 0.96 for fingerstick collec-
tion 1 and 0.93 to 0.96 for fingerstick collection 2.
GeneChip Present/Absent Call Analysis
We analyzed the degree of disagreement in Affymetrix
present/absent calls between the fingerstick collections
and also between the fingerstick and venous collections
for each donor. Disagreement is described as a change in
the present, marginal or absent calls between any two
comparisons. Within each comparison we binned the
average signal intensities of each probe set in the ranges
between 0-100, 101-250, 251-500, 501-1000 and >1001.
We got similar results for all three comparisons that we
performed. There was an inverse correlation between
the signal intensities and the disagreement calls for the
probesets in each bin (Figure 3a, b &3c). In contrast, the
number of probesets in agreement was not affected by
the signal intensities irrespective of their bins, except at
the lowest signal intensities (0-100).
Figure 1
Fingerstick and venipuncture RNA yields and Agilent
2100 bioanalyzer traces including RNA integrity
numbers (RINs). (A) Fingerstick starting material: 70 uL,
venipuncture starting material: 2.5 mL, yields normalized to
70 uL. (B, C, D) Agilent 2100 Bioanalyzer total RNA traces
using the PicoChip (B & C) and the NanoChip (D).
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calls that changed from present to absent and vice versa
to test the hypothesis that a change from absent to
present would indicate higher sensitivity for the method
used. On average, there was a higher number of
disagreement calls, namely, change in call of a probe
set from present in the venipuncture method to absent in
the fingerstick method. However, there were also a
Figure 2
Fingerstick and venipuncture cDNA yields and Agilent 2100 Bioanalyzer traces. The samples included in this figure
refer to the same samples as Figure 1. (A) Yields of cDNA post Nugen Ovation amplification of 50 ng total RNA. Yields of
cDNA from both fingerstick and venipuncture samples were always above the 4.4 ug cut-off needed to continue with
hybridization to GeneChip ( B ,C ,D )Agilent 2100 Bioanalyzer cDNA traces using the NanoChip.
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fingerstick collection to absent in the venipuncture
collection (Table 4). For example, Donor 2 changed
calls from present, in the venipuncture method, to
absent, in the fingerstick method, at an average rate of
6.7%. On the other hand, Donor 2 changed calls from
absent, in the venipuncture method, to present, in the
fingerstick method, at an average rate of 4%.
Table 1: Affymetrix quality metrics for all fingerstick samples
Donor Collection Scale Factor Background % Present GAPDH 3'/5' B-actin 3'/5'
1 Fingerstick 1 4.51 31.1 44.7 32.2 158.6
1 fingerstick 2 2.76 29.9 52.4 7.7 29.4
2 fingerstick 1 2.58 31.9 52.8 6.6 13.3
2 fingerstick 2 2.25 32.1 54.2 6.2 19.7
3 fingerstick 1 2.70 30.8 52.7 4.3 6.6
3 fingerstick 2 2.23 30.2 54.3 5.8 15.0
4 fingerstick 1 2.77 31.2 53.1 5.3 8.8
4 fingerstick 2 2.13 30.2 53.8 6.3 16.8
5 fingerstick 1 2.82 29.7 53.3 4.9 6.9
5 fingerstick 2 2.25 30.9 53.5 7.5 19.1
Average 2.7 30.8 52.5 8.7 29.4
SD 0.7 0.8 2.8 8.3 45.9
Table 2: Affymetrix quality metrics for all venipuncture samples
Donor Collection Scale Factor Background % Present GAPDH 3'/5' B-actin 3'/5'
1 venipuncture 3.10 30.3 56.9 2.9 1.9
2 venipuncture 2.82 29.4 56.4 3.0 1.7
3 venipuncture 3.15 29.0 56.2 2.3 1.7
4 venipuncture 2.52 30.1 56.6 3.0 1.8
5 venipuncture 2.63 28.4 54.1 2.8 1.7
Average 2.8 29.5 56.0 2.8 1.8
SD 0.3 0.8 1.1 0.3 0.1
Table 3: r
2 correlation values for fingerstick and venipuncture samples
F i n g e r s t i c k1v s .F i n g e r s t i c k2 V e n i p u n c t u r ev s .F i n g e r s t i c k1 V e n i p u n c t u r ev s .F i n g e r s t i c k2
Donor 1 0.94 0.88 0.94
Donor 2 0.97 0.95 0.94
Donor 3 0.97 0.96 0.96
Donor 4 0.97 0.96 0.95
Donor 5 0.97 0.95 0.93
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Despite the fact that technologies for RNA isolation have
shown tremendous improvements over the past decade
with RNA isolation kits for tissue, cells as well as whole
blood, there is still no commercially available methodol-
ogy for the isolation of good quality RNA from microliter
volumes of human whole blood suitable for gene
expression profiling on DNA microarrays. To test the
hypothesis that we can isolate excellent quality and
sufficient quantities of RNA from small volumes of whole
blood (<100 μl) we investigated a modified protocol of
whole blood RNA isolation in the present study.
Our results show that we were able to successfully isolate
RNA that gave comparable results with the standard
venous blood method when assayed on an Affymetrix
GeneChip.TheadvantagesofthefingerstickRNAisolation
method were the ease of small volume blood collection,
minimal modification of the standard PAXgene protocol,
no requirement of a trained phlebotomist, and amen-
ability to off-site studies as well as feasibility in studies
involving serial blood collections on a large number of
subjects. The fingerstick RNA was of very high quality,
comparabletothevenousbloodRNAwhenassayedbythe
Agilent Bioanalyzer with no signs of degradation despite
the technical differences between a venipuncture and a
fingerstick collection. It is important to note that even
though the volume of blood used in the fingerstick
collection was small, the DNase treatment of the RNA
was found to be crucial. This was especially necessary for
the accurate quantitation of the RNA since the Nugen
protocol calls for nanogram quantities of RNA as the
starting material. The accurate quantitation of RNA could
be biased due to the presence of contaminating DNA.
The yields of amplified cDNA were only slightly higher in
the venipuncture method compared to both fingerstick
collections. However, the Agilent Bioanalyzer traces for
the amplified cDNA from the Nugen protocol showed no
differences between the two collection methods. The
quality control metrics for the GeneChip data showed
that the venous collections had slightly higher average
percent present calls (3.5% more) but this could reflect
the inherent biological differences between venous and
capillary blood. In a recent publication, Schalk et al.,
show that there are significantly higher WBC and RBC
counts in capillary blood but lower numbers of platelets
[ 2 2 ] .S u c hd i f f e r e n c e sc a nc o n t r i b u t et oa l t e r e dg e n e
expression in these two compartments of blood. In the
design of any study this would not be a major influencing
factor since cross-comparisons between two different
methodologies and sources of samples is not very
informative in gene expression studies.
On further analysis we showed that the differences are
mainly due to the flux between calls at the lower signal
intensities (<100), which accounts for almost all the
variation between the methodologies. On average only
about 12% of the total probesets on the GeneChip
Figure 3
Inverse correlations between signal intensities and
number of disagreement calls.T h ef i g u r e sA, B, and C
illustrate the inverse correlation between signal intensities
and the number of disagreement calls; as the signal intensity
increases, the disagreement calls between fingerstick samples
and venipuncture samples drastically decreases.
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which is well within the range of expected variation
between samples in any DNA microarray study (data not
shown). A study which looked at the individuality and
variation in gene expression patterns in human blood
foundthattherewereseveralsignificantvariationsingene
expression among 77 samples of peripheral blood
collected from normal healthy volunteers [23]. The
variation was seen with respect to cellular and physiolo-
gical themes, age, gender as well as temporal variations.
However, the authors conclude that an analysis of multi-
plesequentialsamplesfromthesameindividualsallowed
them to discern donor-specific patterns of gene expres-
sion. Two other similar studies investigating the variation
in gene expression from the peripheral blood of healthy
individuals also concluded that there are significant inter-
individualdifferencesingeneexpressionattributingthem
to genes that were involved in immunoglobulin class
switching, interferon expression, X and Y-linked clusters,
histone rich regions and killer cell function [24,25].
Conclusion
In the present study we demonstrate a simple, modified
RNA isolation protocol from small volumes of whole
blood (70 μL by fingerstick) that is highly comparable to
the standard method of RNA isolation (2.5 mL by
venipuncture). The RNA from the fingersticks were
further assayed on Affymetrix GeneChips and the results
were very similar to the venipuncture collections. We
effectively show that this fingerstick RNA isolation
methodology can be used and should open up a broad
range of applications for whole blood DNA microarray
analysis ranging from pediatric studies to animal studies
where there is access to only smaller volumes of blood.
This methodology is especially suitable for serial
monitoring, field testing, pharmacokinetic assays and
rapid diagnosis of disease states.
Methods
Patient Recruitment
All samples were drawn from normal, healthy volunteers
as part of The Scripps Research Institute’sN o r m a lB l o o d
Drawing Service approved by the Office of Research
Subjects Protection of the Scripps Health Human
Subjects Committee. Both fingerstick and venous blood
samples were collected by a trained phlebotomist.
Sample collection
Sterile, DNase and RNase free, 1.5 mL Eppendorf tubes
pre-filled with 200 μL PAXgene RNA stabilizing reagent
(aliquoted from a PAXgene tube) were prepared and set
aside. The donor finger was cleaned with an alcohol wipe
and stuck with a single-use, spring loaded, retracting
needle lancet (Unistick2 Super Lancet) according to the
manufacturer’s directions. Approximately 70 μl of blood
was immediately collected into a capillary tube (Fish-
erbrand Heparinized Micro-Hematocrit). The sample
was then transferred into the Eppendorf tube containing
the PAXgene solution and the capillary tube was
aspirated with a pipette to increase sample recovery.
The sample was then mixed well with a pipette, given a
quick spin, and left to incubate at room temperature;
allowing complete lysis of blood cells in sample
(PAXgene Blood RNA Kit handbook, http://www1.
qiagen.com/Products/RnaStabilizationPurification/DSP/
PaxGeneBloodRnaKitIVD.aspx#Tabs=t2 [17].
RNA Isolation and Purification
After incubation, we centrifuged the samples at 4500 g
(Eppendorf Centrifuge Model 5804 R) at room tempera-
ture for 15 minutes. After carefully aspirating and
discarding the supernatant, the pellet was washed with
1 mL RNase free water. From this point forward, we
followed the processing guidelines given in the PAXgene
Blood RNA kit (product# 762164) protocol. Note: As the
pellet was often in the form of a streak on the back of the
tube, we used the pipette tip to scrape it from the tube
and fully re-suspend the pellet.
RNA Yield, Purity and Integrity
Due to the small amount of total RNA in the eluate, the
samples were dried in a SpeedVac (Thermo Scientific,
Asheville, NC) to about 20 μL (from the standard 80 μL
elution) before any quality assessment was done. The
Table 4: An analysis of the absolute change and percent change in calls between the fingerstick and venipuncture collections
Venipuncture vs. Fingerstick 1 Donor 1 Donor 2 Donor 3 Donor 4 Donor 5
Pt oA 7704 (14.1%) 3826 (7.0%) 3581 (6.5%) 3725 (6.8%) 3030 (5.5%)
At oP 1359 (2.5%) 1988 (3.6%) 1786 (3.3%) 1894 (3.5%) 2553 (4.7%)
Venipuncture vs. Fingerstick 2 Donor 1 Donor 2 Donor 3 Donor 4 Donor 5
Pt oA 4248 (7.8%) 3486 (6.4%) 3139 (5.7%) 3395 (6.2%) 3054 (5.6%)
At oP 1921 (3.5%) 2360 (4.3%) 2167 (4.0%) 1960 (3.6%) 2716 (5.0%)
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(NanoDrop, Wilmington, DE) to determine the concen-
tration and purity. The Agilent 2100 BioAnalyzer and
accompanying software was used to determine the
integrity and quality of the total RNA.
RNA Amplification, Labeling, and Fragmentation
50 ng aliquots were amplified using the Nugen Ovation®
RNA Amplification System V2 (Cat.# 3100) in conjunc-
tion with the Ovation® WB Reagent (Cat.# 1300). They
were subsequently purified using the Qiagen QIAquick®
PCR Purification Kit (Qiagen, Cat. #28104). Other
purification methods can be used, according to the
Nugen user guide, but we only tested the kit listed
above. Again, the NanoDrop 1000 and Agilent 2100
BioAnalyzer were used to assess sample quantity and
quality. The samples were then labeled and fragmented
using the Nugen FL-Ovation™ cDNA Biotin Module V2
(Cat.# 4200).
cDNA Hybridization and GeneChip Processing
All sample hybridization and GeneChip processing were
done according to the Nugen standard array protocol for
cDNA hybridization (Nugen user guide) and the standard
Affymetrix protocols http://www.affymetrix.com/sup-
port/downloads/manuals/expression_analysis_techni-
cal_manual.pdf [21].
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